Nitto Avecia’s Milford Facility Receives FDA No Action Indicated Classification Following cGMP Inspection Nitto Avecia, a contract development and manufacturing organization (CDMO) specializing in oligonucleotide therapeutics, announced that the U.S.…
Shape Memory Medical Receives ANVISA Authorization for IMPEDE Embolization Plug Portfolio in Brazil Shape Memory Medical Inc., a medical technology company developing volume-expanding shape memory polymer solutions for endovascular embolization,…
NeuroLife Appoints Christopher Coburn and Matthew Thomas to Board as Company Advances Neurotechnology Platform Appoints®, a neurotechnology company focused on developing non-invasive solutions to help restore function and independence for…
Exthymic Receives Up to $25 Million ARPA-H Award to Advance LITTLESTAR Cell Therapy Manufacturing Device Exthymic Corporation, a biotechnology company developing technologies designed to expand access to engineered cell therapies,…
GE HealthCare to Acquire SOFIE Biosciences for $945 Million to Expand U.S. Radiopharmaceutical Manufacturing GE HealthCare (Nasdaq: GEHC) has announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based…
Epicrispr Reports Six-Month Clinical Data for EPI-321 Gene Therapy in FSHD Epicrispr Biotechnologies, a clinical-stage biotechnology company developing epigenetic therapies, has announced updated six-month clinical data from the ongoing first-in-human…
BioCentury Opens Registration for 2027 Grand Rounds Conference in Houston BioCentury has announced that registration is now open for the sixth edition of BioCentury Grand Rounds: US, a translational science-focused…
Catalent Launches Accelerated U.S. Gene-to-Drug Substance Program for Complex Biologics Catalent, Inc., a global contract development and manufacturing organization (CDMO) serving the biopharmaceutical industry, has announced the U.S. launch of…
I2Pure Expands Leadership and Scientific Team to Support Molecular Iodine Manufacturing and Research Growth I2Pure Corp., a biotechnology company focused on patented molecular iodine (I₂) technology for antimicrobial and antiseptic…
Alliance Foundation Trials and Natera Launch Phase III NAVIGATE Trial to Evaluate MRD-Guided Breast Cancer Treatment Alliance Foundation Trials, LLC (AFT), a national organization focused on advancing innovative and practice-changing…
Bayer Plans $2.2 Billion Pharmaceutical Manufacturing Investment in Ohio Bayer has announced plans to invest approximately $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio, marking one…
Roquette to Showcase Pharmaceutical Excipients and Drug Delivery Solutions at CPHI Milan 2026 Roquette, a global provider of pharmaceutical excipients, drug delivery technologies and biopharmaceutical solutions, will showcase its broad…